{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-073957","form_type":"8-K","ticker":"SLS","cik":"0001390478","company_name":"SELLAS Life Sciences Group, Inc.","filed_at":"2024-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.199252+00:00","generated_at":"2026-06-01T02:45:25.442658+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"SELLAS Life Sciences stockholders re-elect two Class II directors and ratify auditor at 2024 annual meeting","bullets":["Scheinberg and Kalin re-elected as Class II directors (8.6M/8.8M for; 18.7M broker non-votes).","Ratified Moss Adams LLP as FY2024 auditor: 27.8M for, 1.7M against, 0.5M abstain.","Advisory 'say-on-pay' passed: 6.0M for, 4.8M against, 0.6M abstain; 18.7M broker non-votes.","Quorum: 30.0M shares (51.95%) represented at meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-073957","json":"https://secwatch.observer/filing/0001104659-24-073957.json","markdown":"https://secwatch.observer/filing/0001104659-24-073957.md","text":"https://secwatch.observer/filing/0001104659-24-073957.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1390478/000110465924073957/0001104659-24-073957-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1390478/000110465924073957/tm2417795d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:45:25.442658+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}